Treatment of Functional Dyspepsia with a Herbal Preparation

Background: We aimed to assess the efficacy and safety of a herbal preparation STW 5-II containing extracts from bitter candy tuft, matricaria flower, peppermint leaves, caraway, licorice root and lemon balm for the treatment of patients with functional dyspepsia. Methods: 120 patients with functional dyspepsia were randomly assigned to 1 of 4 treatment groups. Each patient received the treatment for three consecutive 4-week treatment blocks. The first two treatment blocks were fixed. For the third treatment period, medication was based upon the investigator’s judgement of symptom improvement during the preceding treatment period. In patients without adequate control of symptoms, the treatment was switched, or if symptoms were controlled, the treatment was continued. The primary outcome measure was the improvement of a standardized gastrointestinal symptom score (GIS). Findings: During the first 4 weeks, the GIS significantly decreased in subjects on active treatment compared to the placebo (p < 0.001). During the second 4-week period, symptoms further improved in subjects who continued on active treatment or who switched to the active treatment (p < 0.001), while symptoms deteriorated in subjects who switched to placebo. After 8 weeks 43.3% on active treatment and 3.3% on placebo reported complete relief of symptoms. (p < 0.001 vs. placebo). Conclusion: In patients with functional dyspepsia, the herbal preparation tested improved dyspeptic symptoms significantly better than placebo.

[1]  G. Holtmann,et al.  A randomized placebo‐controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia , 2002, Alimentary pharmacology & therapeutics.

[2]  J. Richter Dyspepsia: organic causes and differential characteristics from functional dyspepsia. , 1991, Scandinavian journal of gastroenterology. Supplement.

[3]  N. Talley,et al.  Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. , 1998, JAMA.

[4]  A. A. Otu Perforated peptic ulcer in south-eastern Nigeria 1973-1982. , 1986, Scandinavian Journal of Gastroenterology, Supplement.

[5]  M. Camilleri,et al.  Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. , 1989, Digestive diseases and sciences.

[6]  A. Andriulli,et al.  Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. , 2000, The New England journal of medicine.

[7]  N. Talley,et al.  The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies , 2002, Gut.

[8]  I. Sassin,et al.  Commerically avallable herbal preparation and its modified dispense in patients with functional dyspepsia. Results of a double-blind, placebo-controlled, randomized multicenter trial , 2001 .

[9]  K. Olden,et al.  The functional gastrointestinal disorders , 1997 .

[10]  W. Rösch Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial. , 1987, Scandinavian journal of gastroenterology.

[11]  S. Köhler,et al.  Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia , 2000, Alimentary pharmacology & therapeutics.

[12]  A. Madisch,et al.  Treatment of Functional Dyspepsia with a Fixed Peppermint Oil and Caraway Oil Combination Preparation as Compared to Cisapride , 1999, Arzneimittelforschung.

[13]  P. Aaronson,et al.  The mechanism of action of peppermint oil on gastrointestinal smooth muscle. An analysis using patch clamp electrophysiology and isolated tissue pharmacology in rabbit and guinea pig. , 1991, Gastroenterology.

[14]  J. Malagelada,et al.  Isobaric intestinal distension in humans: sensorial relay and reflex gastric relaxation. , 1990, The American journal of physiology.

[15]  G. Baxter,et al.  Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid‐related dyspepsia in general practice , 1997, Alimentary pharmacology & therapeutics.

[16]  N. Talley,et al.  Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. , 1999, The New England journal of medicine.

[17]  N. Talley Dyspepsia: how to manage and how to treat? , 2002, Alimentary pharmacology & therapeutics.

[18]  A. Blum,et al.  Short course acid suppressive treatment for patients with functional dyspepsia: results depend onHelicobacter pyloristatus , 2000, Gut.

[19]  P. Malfertheiner,et al.  Drug treatment of functional dyspepsia. , 2006, World journal of gastroenterology.

[20]  N. Talley,et al.  Prognosis of chronic unexplained dyspepsia. A prospective study of potential predictor variables in patients with endoscopically diagnosed nonulcer dyspepsia. , 1987, Gastroenterology.

[21]  Holtmann,et al.  Randomised double‐blind comparison of simethicone with cisapride in functional dyspepsia , 1999, Alimentary pharmacology & therapeutics.

[22]  G Wassmer,et al.  Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate. , 1991, Biometrics.

[23]  A. Blum,et al.  Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. , 1998, The New England journal of medicine.

[24]  N. Alley,et al.  Drug treatment of functional dyspepsia. , 1991 .

[25]  M. Wahl,et al.  GASTROINTESTINAL MOTILITY MODULATION WITH IBEROGAST , 1993 .

[26]  Nj Talley,et al.  Functional dyspepsia : a classification with guidelines for diagnosis and management , 1991 .

[27]  D. Piper,et al.  Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia. , 1986, Gastroenterology.

[28]  A R Zinsmeister,et al.  esign of Treatment Trials for Functional Gastrointestinal isorders esign of Treatment Trials Committee : , 2006 .

[29]  P. O'Brien Procedures for comparing samples with multiple endpoints. , 1984, Biometrics.

[30]  A. Madisch,et al.  Benefit of a herbal preparation in patients with irritable bowel syndrome: Results of a double-blind, randomized, placebo-controlled multicenter trial , 2000 .

[31]  N. Talley,et al.  Non-ulcer dyspepsia: potential causes and pathophysiology. , 1988, Annals of internal medicine.

[32]  M. Hughes,et al.  Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia. , 1998, Journal of clinical gastroenterology.

[33]  Talley,et al.  Efficacy of omeprazole in functional dyspepsia: double‐blind, randomized, placebo‐controlled trials (the Bond and Opera studies) , 1998, Alimentary pharmacology & therapeutics.

[34]  H. Glise,et al.  Effect of Profound Acid Suppression in Functional Dyspepsia: a Double-Blind, Randomized, Placebo-Controlled Trial , 2002, Scandinavian journal of gastroenterology.